CD99 and PFKFB3 have been previously found to mediate metabolic reprogramming, chemoresistance, metastasis, and stemness in ovarian cancer, likely via the modulation of inhibitors of apoptotic proteins and the NF-κB signaling pathway [67]. This evidence concerns the gene PFKFB3 and ovarian cancer.